Bibliographic information
GuidelineLiving guidance for clinical management of COVID-19: living guidance, 23 November 2021.
Year of Publication2021
Issuing InstitutionWorld Health Organization
Recommendation
Maintained
The World Health Organization (WHO) recommends, in hospitalized patients with COVID-19, without an established indication for higher dose anticoagulation, we suggest administering standard thromboprophylaxis dosing of anticoagulation rather than therapeutic or intermediate dosing.
Recommended in favor
Conditional
Certainty of evidence
Very low
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
COVID-19 clinical management: living guidance, 25 January 2021.
Year2021
InstitutionWorld Health Organization
Guideline
Clinical management of COVID-19: living guideline, 23 June 2022.
Year2022
InstitutionWHO
Guideline
Clinical management of COVID-19: living guideline, 15 September 2022.
Year2022
InstitutionWHO
Guideline
Clinical management of COVID-19: living guideline, 13 January 2023.
Year2023
InstitutionWHO
Guideline
Clinical management of COVID-19: living guideline, 18 August 2023
Year2023
InstitutionWHO